The role of the endocannabinoidsystem and the immune system in chronic pain - alterations in comparison to healthy volunteers and influence of pain treatment
- Conditions
- R52.2Other chronic pain
- Registration Number
- DRKS00005954
- Lead Sponsor
- Interdisziplinäre Schmerzambulanz und Tageskinik, LMU München, Klinikum Großhadern
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 98
Inclusion Criteria
Patients with chronic nociceptive and/or neuropathic pain without medication or stable medication for at least 14 days
Exclusion Criteria
Pregnancy, psychological/mental disorder, addiction, glucocorticoid treatment
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Before and after standard treatment: Pain level: NRS, Stresslevel: KAB, Cytokines: Immunassay, Endocannabinoids: Mass-spektrometry, T cells: Flow cytometry, mRNA-expression: RT-PCR
- Secondary Outcome Measures
Name Time Method Influences of routine standard pain treatment on the primary outcome parameters.<br>